全球鼓膜造口管市场 - 2023-2030

概述

耳管（也称为鼓膜切开管或鼓室造口管）是一种微小的管子，由儿科耳鼻喉 (ENT) 外科医生透过手术放置在儿童的耳膜中，以帮助治疗耳部感染。

此管的目的是为中耳提供通风并防止液体积聚。使用此管的主要适应症是耳咽管功能障碍导致渗出性中耳炎或浆液性中耳炎。这些鼓膜造口管提供通气，平衡中耳的张力，并避免进一步的復发感染。

市场动态：驱动因素与限制因素

小儿耳部感染高发生病例

儿科耳部感染的高盛行率预计将在预测期内推动全球市场的成长。例如，根据约翰霍普金斯大学的研究，婴儿和幼儿的耳部感染非常典型。此外，根据美国国立卫生研究院的数据，预计六分之五的儿童在 3 岁之前会出现耳部感染。超过 80% 的儿童在 3 岁时至少患有一次耳部感染。在美国，每年有近 3,000 万人次因耳部感染而去看儿科医生，这是儿童就医最常见的原因。

此外，不断增长的技术进步和不断提高的意识等预计将有助于预测期内全球市场的成长。

产品相关风险

放入耳管会带来严重问题的风险，包括出血、感染、持续排液、血液或黏液堵塞耳管、鼓膜疤痕或变弱、耳管过早脱落或停留时间过长以及耳膜在插管后未闭合脱落或取出，阻碍了预测期内的全球市场成长。此外，其他限制因素包括严格的监管机构、高产品开发成本、取代基认知度和可用性低等。

目录

第 1 章：方法与范围

• 研究方法论
• 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

• 按材料分类的片段
• 按应用程式片段
• 最终使用者的片段
• 按地区分類的片段

第 4 章：动力学

• 影响因素
  • 司机
    • 小儿耳部感染高发生病例
  • 限制
    • 产品相关风险
  • 机会
  • 影响分析

第 5 章：产业分析

• 波特五力分析
• 供应链分析
• 定价分析
• 监管分析
• 报销分析
• 专利分析
• 科技趋势
• 流行病学
• SWOT分析
• DMI 意见

第 6 章：COVID-19 分析

• COVID-19 分析
  • 新冠疫情爆发前的情景
  • 新冠疫情期间的情景
  • 新冠疫情后的情景
• COVID-19 期间的定价动态
• 供需谱
• 疫情期间政府与市场相关的倡议
• 製造商策略倡议
• 结论

第 7 章：按材料

• 硅酮
• 氟塑料
• 其他材料

第 8 章：按应用

• 急性中耳炎
• 復发性中耳炎伴随渗出液

第 9 章：最终用户

• 医院
• 专科诊所
• 门诊手术中心 (ASC)
• 其他的

第 10 章：按地区

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 亚太其他地区
• 中东和非洲

第 11 章：竞争格局

• 竞争场景
• 市场定位/份额分析
• 併购分析

第 12 章：公司简介

• EON Meditech Pvt. Ltd
• 公司简介
• 产品组合和描述
• 财务概览
• 主要进展
• Atos Medical
• Medtronic PLC, Inc.
• Olympus Corporation
• Preceptis Medical
• Smith & Nephew
• Integra LifeSciences Corporation, Inc.
• Grace Medical
• Koken Co., Ltd.
• Summit Medical LLC

第 13 章：附录

Overview

Ear tubes (also anointed myringotomy tubes or tympanostomy tubes) are tiny tubes that are surgically positioned in the child's eardrum by a pediatric ear, nose, and throat (ENT) surgeon to aid in treating ear infections.

The purpose of the tube is to provide ventilation to the middle ear and prevent liquid buildup. The primary indication for the usage of this tube is eustachian tube dysfunction directing to otitis media with effusion or serous otitis media. These tympanostomy tubes deliver ventilation, equalize tension in the middle ear, and avert further recurrent infections.

Market Dynamics: Drivers & Restraints

High Prevalence Pediatric Ear Infection Cases

The high prevalence of pediatric ear infections is expected to boost the global market growth during the forecast period. For instance, according to Johns Hopkins University, ear infections in infants and toddlers are extremely typical. Moreover, according to the National Institutes of Health, five in six children are expected to encounter an ear infection before the age of 3. Over 80% of children have at least one ear infection by the time they are 3 years old. In the U.S., ear infections make up for almost 30 million visits to the pediatrician each year the most common reason children visit their doctor.

Furthermore, growing technological advancements and growing awareness among others are expected to contribute to the global market growth during the forecast period.

Product Associated Risks

Putting in an ear tube carries a risk of serious problems including bleeding, infection, ongoing fluid drainage, blocked tubes from blood or mucus, eardrum scarring or weakening, tubes falling out too soon or staying in too long and the eardrum not closing after the tube falls out or is taken out, hampering the global market growth during the forecast period. Moreover, other restraining factors include stringent regulatory bodies, high product development costs, low awareness and avalibility of substituents among others.

Segment Analysis

The global tympanostomy tube market is segmented based on material, application, end user and region.

Acute Otitis Media (AOM) is Expected to Dominate Market

Acute otitis media (AOM) is described as an infection of the middle ear and is the second most typical pediatric infection diagnosis in the emergency division following upper respiratory infections. Although acute otitis media can transpire at any age, it is highly typical to be detected between the ages of 6 to 24 months. The high prevalence of acute otitis media is expected to boost segment growth during the forecast period.

For instance, according to NIH, roughly 80% of all children are estimated to experience a case of otitis media in their lifetime, and between 80% to 90% of all children are expected to have otitis media with an effusion before school age. Moreover, according to the American Academy for Pediatrics, more than 5,000,000 AOM cases surface annually in US children.

Geographical Analysis

North America is Expected to Dominate the Global Market

Owing to the high prevalence and increasing adoption of Tympanostomy Tube treatment in North America the region is estimated to dominate the global market throughout the forecast period. For instance, in 2021, an NIH investigation documented that ear infections were among the most typical infections in United States children yearly.

Moreover, according to the National Institute on Deafness and Other Communication Disorders in March 2021, 5 out of 6 children in the United States experience ear infection by the time they are three years old. Further, in August 2022, Phoenix Children's Hospital executed an ear tube replacement surgery utilizing the Hummingbird tympanostomy tubes on a patient under two years old with a constant ear infection in the United States.

COVID-19 Impact Analysis

It is confirmed that the COVID-19 pandemic has directed to significant transformations in healthcare delivery, with telehealth evolving more widely embraced to minimize transmission. New policies were also issued, which outlined new protocols for evaluating and managing common pediatric ear, nose, and throat infections.

These modifications have in some cases postponed or substituted surgical interventions. Further, ongoing investigation has directed to new understandings into the pathophysiology of specific pediatric diseases, including otitis media, which suggests that upper respiratory infection exposure may play a larger role than previously thought.

Market Segmentation

By Material

• Silicone
• Fluoroplastic
• Other Materials

By Application

• Acute Otitis Media
• Recurrent Otitis Media with Effusion

By End User

• Hospital
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In August 2022, Perceptis Medical Inc. obtained United States FDA authorization for the Hummingbird Tympanostomy tube system for extended indications for usage in office pediatric ear tube procedures.
• In February 2022, Medtronic introduced the NuVenet Eustachian tube dilation balloon, it is employed in the treatment of the eustachian tube from pathogens, equalizing air pressure on either side of the eardrum and aiding drain secretion from the middle ear cleft.

Competitive Landscape

The major global players in the market include: EON Meditech Pvt. Ltd, Atos Medical, Medtronic PLC, Olympus Corporation, Preceptis Medical, Smith & Nephew, Integra Lifesciences Corporation, Grace Medical, Summit Medical LLC and Koken Co., Ltd. Among others.

Why Purchase the Report?

• To visualize the global tympanostomy tube market segmentation based on material, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of tympanostomy tube market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global tympanostomy Tube market report would provide approximately 61 tables, 57 figures and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Material
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. High Prevalence Pediatric Ear Infection Cases
  • 4.1.2. Restraints
    • 4.1.2.1. Product Associated Risks
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. Technology Trend
• 5.8. Epidemiology
• 5.9. SWOT Analysis
• 5.10. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Material

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 7.1.2. Market Attractiveness Index, By Material
• 7.2. Silicone*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Fluoroplastic
• 7.4. Other Materials

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Acute Otitis Media*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Recurrent Otitis Media with Effusion

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospital*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory Surgical Centers (ASCs)
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. EON Meditech Pvt. Ltd*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Atos Medical
• 12.3. Medtronic PLC, Inc.
• 12.4. Olympus Corporation
• 12.5. Preceptis Medical
• 12.6. Smith & Nephew
• 12.7. Integra LifeSciences Corporation, Inc.
• 12.8. Grace Medical
• 12.9. Koken Co., Ltd.
• 12.10. Summit Medical LLC

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us